Therapy News and Research

RSS

Remote diabetes management using CGM and telemedicine visits can improve glycemic control

New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.

22 Sep 2021

Penn Medicine and Wistar secure $11.7 million SPORE grant for three melanoma research projects

Penn Medicine and The Wistar Institute have been awarded a prestigious $11.7 million Specialized Programs of Research Excellence, or SPORE, grant from the National Cancer Institute.

22 Sep 2021

Pinning down Pin1: Potential COVID-19 therapy

In a recent study scientists have demonstrated that Pin1 is one of the key cellular molecules necessary for SARS-CoV-2 propagation.

22 Sep 2021

COVID-19 vaccination in IBD patients

In this review, researchers reviewed all published research related to Phase 1/2 and/or Phase 3 and 4 studies of SARS-CoV-2 vaccinations.

22 Sep 2021

Compound extracted from orchid could be a potential treatment option for prostate cancer

Research led by the Centenary Institute has found that a compound extracted from a commonly cultivated orchid could be a potential new treatment option for prostate cancer.

22 Sep 2021

Study supports the implementation of Beckman Coulter’s MDW in emergency labs as initial test to detect sepsis

Beckman Coulter announced the results of a prospective study carried out across two European hospitals, which found that Monocyte Distribution Width, in combination with White Blood Cell Count with Differential, has the diagnostic accuracy to detect the risk of sepsis and severe infection upon patient presentation in A&E, particularly when assessed in patients with a lower likelihood of sepsis.

22 Sep 2021

Cardiothoracic surgeons implant novel type of artificial heart in a female patient

A cardiothoracic surgical team with UofL Health – Jewish Hospital and the University of Louisville has performed the world's first Aeson® bioprosthetic total artificial heart implantation in a female patient. The investigational device, currently intended as a bridge to heart transplant, is part of an Early Feasibility Study (EFS) sponsored by CARMAT, a French medical device company, in partnership with UofL, UofL Health – Jewish Hospital and the UofL Health – Trager Transplant Center.

22 Sep 2021

Revival of the cell and gene therapy field opens new avenues for repairing the Parkinsonian brain

After several decades of pre-clinical development, cell- and gene-based therapies for Parkinson's disease (PD) are now actively being explored.

21 Sep 2021

Artificial intelligence predicts the risk of metastatic relapse in breast cancer patients

The RACE AI study conducted by Gustave Roussy and the startup Owkin, as part of the AI for Health Challenge organized by the Ile-de-France Region in 2019, was presented as a proffered paper at ESMO.

21 Sep 2021

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Researchers recently investigated the effect of infection with SARS-CoV-2 in patients with hematologic malignancies in minority populations.

21 Sep 2021

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.

21 Sep 2021

Study outlines a baseline bundle of care interventions for critically ill patients

Critical illness results in millions of deaths globally every year, many of which could be avoided with basic, life-saving care. Now, a new study led by researchers at Karolinska Institutet in Sweden outlines a baseline bundle of care interventions that global experts agree should be available for all critically ill patients. The study, published in the journal BMJ Global Health, provides a blueprint for hospitals on how to reduce preventable deaths, including from COVID-19.

21 Sep 2021

Physical activity may hasten plaque build-up in the coronary arteries, finds research

Physical activity may paradoxically hasten the build-up of calcium deposits (plaque) in the coronary arteries, the amount of which is used to assess future cardiovascular disease risk, finds research published online in the journal Heart.

21 Sep 2021

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

Researchers from the Akershus University Hospital in Norway investigated 77 cases of CVT in vaccinated subjects to identify risks and warning signs to better predict these severe side effects.

21 Sep 2021

California’s reboot of troubled Medi-Cal puts pressure on health plans

When Denise Williams' baby boy was 2 months old, she became alarmed by a rattling sound in his lungs and took him to the emergency room. While undergoing treatment, he spiraled into a disabling neurological disorder.

21 Sep 2021

Ultrasonic Flow Meter Ideal for Ultra-Pure Water Applications

Designed primarily for ultra-pure water dispensing applications requiring a high degree of cleanliness, clean bore flow measurement devices such as Titan Enterprises’ Metraflow® ultrasonic flowmeter, offer the ideal solution.

From Titan Enterprises Ltd 21 Sep 2021

Decline in SARS-CoV-2 neutralizing antibodies and unique cytokine profile in severe COVID-19 patients

A new study has focused on antibody levels and cytokine profiles of COVID-19 patients with mild symptoms, pneumonia, and severe pneumonia.

21 Sep 2021

Careful pipetting reduces the stress on cells in culture

Cell viability, defined as the proportion of live cells in a sample, is a fundamental consideration in all cell culture techniques.

From INTEGRA Biosciences 21 Sep 2021

Clinical trial reveals optimal period for intensive rehabilitation of arm and hand use after stroke

A phase II, randomized clinical trial found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should begin 60 to 90 days after the event.

21 Sep 2021

Novel anti-hormonal therapy may be a new treatment option for early-stage breast cancer

Early results from a UCLA-led clinical trial found treating women with estrogen receptor (ER)-positive and human epidermal growth factor receptor-2 (HER2)-negative early breast cancers with a novel type of anti-hormonal therapy, called an oral selective estrogen receptor degrader (SERD), led to clinically meaningful reductions in tumor activity prior to surgery.

21 Sep 2021

Therapy News and Research

Remote diabetes management using CGM and telemedicine visits can improve glycemic control

Penn Medicine and Wistar secure $11.7 million SPORE grant for three melanoma research projects

Pinning down Pin1: Potential COVID-19 therapy

COVID-19 vaccination in IBD patients

Compound extracted from orchid could be a potential treatment option for prostate cancer

Study supports the implementation of Beckman Coulter’s MDW in emergency labs as initial test to detect sepsis

Cardiothoracic surgeons implant novel type of artificial heart in a female patient

Revival of the cell and gene therapy field opens new avenues for repairing the Parkinsonian brain

Artificial intelligence predicts the risk of metastatic relapse in breast cancer patients

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Study outlines a baseline bundle of care interventions for critically ill patients

Physical activity may hasten plaque build-up in the coronary arteries, finds research

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

California’s reboot of troubled Medi-Cal puts pressure on health plans

Ultrasonic Flow Meter Ideal for Ultra-Pure Water Applications

Decline in SARS-CoV-2 neutralizing antibodies and unique cytokine profile in severe COVID-19 patients

Careful pipetting reduces the stress on cells in culture

Clinical trial reveals optimal period for intensive rehabilitation of arm and hand use after stroke

Novel anti-hormonal therapy may be a new treatment option for early-stage breast cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News